Biotec Pharmacon ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotec Pharmacon ASA with three other
pharmaceutical manufacturers in Europe:
sales of 9.08 million Euro [US$10.59 million]
of which 100%
was Research & Development),
Swedencare AB (publ)
(53.72 million Swedish Kronor [US$6.54 million]
based in Bulgaria
(17.70 million Bulgarian Lev [US$10.53 million]
During the year ended December of 2016, sales at
Biotec Pharmacon ASA were NOK 71.90 million (US$9.02 million).
increase of 35.0%
versus 2015, when the company's sales were NOK 53.28 million.
This was the fourth straight year of sales growth at Biotec Pharmacon ASA.